Long-term persistent mixed chimerism in a patient with Wiskott–Aldrich syndrome after allogeneic hematopoietic stem cell transplantation

Cover Page

Cite item

Full Text

Abstract

The article describes a clinical case of a patient with Wiskott–Aldrich syndrome, in whom long- term persistence of mixed chimerism was determined after hematopoietic stem cell transplantation (HSCT) from a haploidentical donor. Based on the analysis of the patient's clinical picture after HSCT, it was shown that the presence of> 50% of donor cells in the myeloid lineage is necessary for the correction of thrombocytopenia. In addition, the presence of mixed chimerism in B-lymphocytes possibly contributed to the development of autoimmune complications in the patient, as well as to the persistent hypogammaglobulinemia, despite the restoration of the normal numbers of lymphocytes in all main sub-populations. The role of mixed chimerism in the pathogenesis of immune post-transplant complications requires study in large groups of patients with primary immunodeficiencies. The patient's parents agreed to use the information, including the child's photo, in scientific research and publications.

About the authors

V. О. Bludova

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

Author for correspondence.
Email: voevodina_1996@list.ru

Viktoriya O. Bludova, a resident 

 1 Samory Mashela St., Moscow 117997

Russian Federation

A. L. Laberko

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

Yu. A. Rodina

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

V. V. Brilliantova

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

E. V. Raykina

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

A. L. Khoreva

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

D. E. Pershin

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

G. V. Tereshchenko

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

A. Yu. Shcherbina

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare
of the Russian Federation

 1 Samory Mashela St., Moscow 117997

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bludova V.О., Laberko A.L., Rodina Y.A., Brilliantova V.V., Raykina E.V., Khoreva A.L., Pershin D.E., Tereshchenko G.V., Shcherbina A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.